Lista de obras - Antoni X Torres-Collado - Dominio Público Uruguay

ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells.

artículo científico publicado en 2010

ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.

artículo científico publicado en 2006

Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor

artículo científico publicado en 2014

Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs

scientific article published on 01 April 2005

Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy

artículo científico publicado en 2015

Circumvention of drug-resistance via decitabine-mediated DNMT1 depletion

artículo científico publicado en 2013

Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.

artículo científico publicado en 2008

Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.

artículo científico publicado en 2013

Epigenetic biomarker of metastatic melanoma.

artículo científico publicado en 2013

Epigenetic fine-tuning of NF-κB-Sox9 circuitry in cancer stem cells

scholarly article by Ali R Jazirehi & Antoni X Torres-Collado published 1 August 2013 in Epigenomics

Epigenetic regulation of retinoic acid susceptibility in leukemia.

artículo científico publicado en 2013

Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis

artículo científico publicado en 2010

Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.

artículo científico publicado en 2018

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor).

artículo científico publicado en 2018

Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1.

artículo científico publicado en 2012

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

artículo científico publicado en 2009

Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.

artículo científico publicado en 2010

Lista de obras de Antoni X Torres-Collado

ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells.

ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.

Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor

Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs

Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy

Circumvention of drug-resistance via decitabine-mediated DNMT1 depletion

Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.

Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.

Epigenetic biomarker of metastatic melanoma.

Epigenetic fine-tuning of NF-κB-Sox9 circuitry in cancer stem cells

Epigenetic regulation of retinoic acid susceptibility in leukemia.

Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis

Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor).

Selective decline of synaptic protein levels in the frontal cortex of female mice deficient in the extracellular metalloproteinase ADAMTS1.

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.